Olympus announced today the results of a pilot study showing the safety and effectiveness of the ViziShot 2 FLEX 19 G EBUS-TBNA Needle in gathering tissue samples critical to guiding treatment of non-small cell lung cancer (NSCLC).
Boston Scientific completes the acquisition of the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA).
MicroCNX connectors are a critically important option for a range of bioprocessing, cell therapy and gene therapy workflows,.”Until now, cumbersome tube welding has been the only way to make sterile closed connections of very small-bore tubing. The MicroCNX connector represents a huge innovation for the industry.
Scientists from The University of Texas at Austin took an important step toward safer gene editing cures for life-threatening disorders, from cancer to HIV to Huntington’s disease, by developing a technique that can spot editing mistakes a popular tool known as CRISPR makes to an individual’s genome. The research appears today in the journal Cell.
By developing nanoparticle “backpacks” that hold immune-stimulating drugs, and attaching them directly to T cells, the MIT engineers showed in a study of mice that they could enhance those T cells’ activity without harmful side effects. In more than half of the treated animals, tumors disappeared completely.
Biotechnology Innovation Platform Launch expected to become a national-level technology startup incubator. It aims to host at least 50 spinoff companies and commercialize the results of at least 10 HKU research projects within five years. The platform will focus on key areas including cancer treatment, medical devices and infectious disease treatment.
Realtime Flexible Sensor for Healing HKU Engineering and Medicine collaborate and develop a real-time flexible sensor...
Researchers at Caltech have developed an artificial neural network made out of DNA that can solve a classic machine learning problem: correctly identifying handwritten numbers. The work is a significant step in demonstrating the capacity to program artificial intelligence into synthetic biomolecular circuits.
More than a century after its discovery, no effective prevention or treatment exists for this progressive deterioration of brain tissue, memory and identity. With more people living to older ages, there is a growing need to clarify Alzheimer’s disease risk factors and disease mechanisms and use this information to find new ways in which to treat and prevent this terrible disorder.
A study recently published in the journal Magnetic Resonance in Medicine and co-authored by Stanford life-science research assistant Itamar Terem, then-postdoc Samantha Jane Holdsworth, PhD, (now at the University of Auckland) and several other Stanford colleagues describes a new imaging method that, by means of a kind of strobe-action amplification technique, is able to visually blow up the minute heartbeat-induced pulsations of the brain to produce mind-boggling video sequences such as the one you’ve hopefully taken a peek at here.
Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.
ACROMEC Limited (“ACROMEC”, SGX:43F), an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, research and academia sectors, has secured three new contracts totaling approximately S6.2 million.